Urology

Showing results 61 - 70 of 100

Sorted by most recent

TitleAuthorDate

Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study

Jianyi Zheng, Shijie Li, Yiqiao Zhao, Zijia Tao, Lei Li, Zeyu Li, Mingyang Li, Xiaonan Chen

1 September 2022

eaberry in the treatment of acute uncoplcated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial

Barbara Tóth, András Jávorházy, Péter Nyirády, Boglárka Csupor-Löffler, Péter Birinyi, George Zhanel, Kurt Naber, Reinhard Länger, Nóra Vörhendi, Noémi Gede, Szilárd Váncsa, Péter Hegyi, Dezső Csupor

24 June 2022

Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial)

Daniel A Galvão, Dennis R Taaffe, Dickon Hayne, Pedro Lopez, P Lyons-Wall, Colin I Tang, Suzanne K Chambers, Amanda Devine, Nigel Spry, Emily Jeffery, Christine Kudiarasu, David Joseph, Robert U Newton

6 June 2022

Development of a novel predictive model for a successful stone removal after flexible ureteroscopic lithotripsy based on ipsilateral renal function: a single-centre, retrospective cohort study in China

Yucheng Ma, Zhongyu Jian, Liyuan Xiang, Liang Zhou, Xi Jin, Deyi Luo, Hong Li, Kun-Jie Wang

1 June 2022

Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review

Tom Vredeveld, Esther van Benten, Rikie E P M Beekmans, M Patrick Koops, Johannes C F Ket, Jurgen Mollema, Stephan P J Ramaekers, Jan J M Pool, Michel W Coppieters, Annelies L Pool-Goudzwaard

29 April 2022

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol

Aino Siltari, Jarno Riikonen, Juha Koskimäki, Tomi Pakarainen, Otto Ettala, Peter Boström, Heikki Seikkula, Andres Kotsar, Teuvo Tammela, Mika Helminen, Paavo V Raittinen, Terho Lehtimäki, Mikkel Fode, Peter Østergren, Michael BorreSee the full list of authors

29 April 2022

Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol

Uwe Bieri, Michael Scharl, Silvan Sigg, Barbara Maria Szczerba, Yasser Morsy, Jan Hendrik Rüschoff, Peter Hans Schraml, Michael Krauthammer, Lukas John Hefermehl, Daniel Eberli, Cédric Poyet

18 April 2022

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0)

Otto Ettala, Ivan Jambor, Ileana Montoya Perez, Marjo Seppänen, Antti Kaipia, Heikki Seikkula, Kari T Syvänen, Pekka Taimen, Janne Verho, Aida Steiner, Jani Saunavaara, Ekaterina Saukko, Eliisa Löyttyniemi, Daniel D Sjoberg, Andrew VickersSee the full list of authors

15 April 2022

Zirconium-labelled girentuximab (Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma

Mohammed Al-Zubaidi, Pravin Viswambaram, Steve McCombie, Elizabeth Liow, Nat Lenzo, Tom Ferguson, Andrew D Redfern, Richard Gauci, Dickon Hayne

15 April 2022

Single use versus reusable catheters in intermittent catheterisation for treatment of urinary retention: a protocol for a multicentre, prospective, randomised controlled, non-inferiority trial (COMPaRE)

Tess van Doorn, Sophie A Berendsen, Jeroen R Scheepe, Bertil F M Blok

11 April 2022

Prev 1 2 3 4 5 678 9 10 Next